Specialty Retail
Compare Stocks
5 / 10Stock Comparison
NHTC vs QNST vs AVAV vs NUS vs USNA
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
Aerospace & Defense
Household & Personal Products
Packaged Foods
NHTC vs QNST vs AVAV vs NUS vs USNA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Advertising Agencies | Aerospace & Defense | Household & Personal Products | Packaged Foods |
| Market Cap | $36M | $761M | $8.40B | $345M | $359M |
| Revenue (TTM) | $38M | $1.18B | $1.61B | $1.49B | $925M |
| Net Income (TTM) | $-1M | $-30M | $-224M | $160M | $11M |
| Gross Margin | 73.8% | 10.5% | 21.8% | 69.4% | 76.6% |
| Operating Margin | -5.1% | 1.7% | -8.3% | 4.4% | 5.5% |
| Forward P/E | — | 10.5x | 58.4x | 7.0x | 11.2x |
| Total Debt | $3M | $10M | $64M | $364M | $14M |
| Cash & Equiv. | $7M | $101M | $41M | $239M | $158M |
NHTC vs QNST vs AVAV vs NUS vs USNA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 100 | 43.8 | -56.2% |
| QuinStreet, Inc. (QNST) | 100 | 131.8 | +31.8% |
| AeroVironment, Inc. (AVAV) | 100 | 237.4 | +137.4% |
| Nu Skin Enterprises… (NUS) | 100 | 18.9 | -81.1% |
| USANA Health Scienc… (USNA) | 100 | 23.0 | -77.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NHTC vs QNST vs AVAV vs NUS vs USNA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NHTC is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 0 yrs, beta 0.58, yield 25.0%
- Lower volatility, beta 0.58, Low D/E 13.4%, current ratio 2.50x
- Beta 0.58, yield 25.0%, current ratio 2.50x
- Beta 0.58 vs AVAV's 1.57
QNST ranks third and is worth considering specifically for growth exposure.
- Rev growth 78.3%, EPS growth 114.2%, 3Y rev CAGR 23.4%
- 78.3% revenue growth vs NUS's -14.3%
AVAV is the clearest fit if your priority is long-term compounding.
- 498.3% 10Y total return vs QNST's 288.4%
NUS carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (7.0x vs 11.2x)
- 10.8% margin vs AVAV's -13.9%
- +26.3% vs USNA's -31.4%
- 11.3% ROA vs QNST's -5.9%, ROIC 7.3% vs 2.8%
Among these 5 stocks, USNA doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 78.3% revenue growth vs NUS's -14.3% | |
| Value | Lower P/E (7.0x vs 11.2x) | |
| Quality / Margins | 10.8% margin vs AVAV's -13.9% | |
| Stability / Safety | Beta 0.58 vs AVAV's 1.57 | |
| Dividends | 25.0% yield, vs NUS's 3.4%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +26.3% vs USNA's -31.4% | |
| Efficiency (ROA) | 11.3% ROA vs QNST's -5.9%, ROIC 7.3% vs 2.8% |
NHTC vs QNST vs AVAV vs NUS vs USNA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NHTC vs QNST vs AVAV vs NUS vs USNA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NUS leads in 1 of 6 categories
USNA leads 1 • NHTC leads 1 • QNST leads 0 • AVAV leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NUS and USNA each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAV is the larger business by revenue, generating $1.6B annually — 42.1x NHTC's $38M. NUS is the more profitable business, keeping 10.8% of every revenue dollar as net income compared to AVAV's -13.9%. On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $38M | $1.2B | $1.6B | $1.5B | $925M |
| EBITDAEarnings before interest/tax | -$2M | $26M | $82M | $118M | $91M |
| Net IncomeAfter-tax profit | -$1M | -$30M | -$224M | $160M | $11M |
| Free Cash FlowCash after capex | -$6M | $99M | -$183M | $46M | $9M |
| Gross MarginGross profit ÷ Revenue | +73.8% | +10.5% | +21.8% | +69.4% | +76.6% |
| Operating MarginEBIT ÷ Revenue | -5.1% | +1.7% | -8.3% | +4.4% | +5.5% |
| Net MarginNet income ÷ Revenue | -3.0% | -2.6% | -13.9% | +10.8% | +1.2% |
| FCF MarginFCF ÷ Revenue | -16.5% | +8.4% | -11.3% | +3.1% | +0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -14.3% | +28.3% | +143.4% | -16.9% | +5.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.4% | +59.4% | -51.5% | +139.7% | -142.2% |
Valuation Metrics
NUS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 2.2x trailing earnings, NUS trades at a 99% valuation discount to QNST's 165.6x P/E. On an enterprise value basis, USNA's 2.4x EV/EBITDA is more attractive than AVAV's 103.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $36M | $761M | $8.4B | $345M | $359M |
| Enterprise ValueMkt cap + debt − cash | $32M | $671M | $8.4B | $471M | $215M |
| Trailing P/EPrice ÷ TTM EPS | -41.72x | 165.55x | 108.50x | 2.21x | 33.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.47x | 58.41x | 7.02x | 11.18x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 21.84x | 102.96x | 3.29x | 2.37x |
| Price / SalesMarket cap ÷ Revenue | 0.90x | 0.70x | 10.23x | 0.23x | 0.39x |
| Price / BookPrice ÷ Book value/share | 1.57x | 3.19x | 5.34x | 0.44x | 0.62x |
| Price / FCFMarket cap ÷ FCF | — | 9.18x | — | 7.50x | 42.13x |
Profitability & Efficiency
USNA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NUS delivers a 20.4% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-11 for QNST. USNA carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NUS's 0.45x. On the Piotroski fundamental quality scale (0–9), QNST scores 8/9 vs NHTC's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.9% | -11.1% | -6.4% | +20.4% | +1.8% |
| ROA (TTM)Return on assets | -2.9% | -5.9% | -5.0% | +11.3% | +1.5% |
| ROICReturn on invested capital | -6.5% | +2.8% | +3.6% | +7.3% | +8.6% |
| ROCEReturn on capital employed | -6.1% | +2.4% | +4.5% | +7.9% | +8.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 8 | 3 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.13x | 0.04x | 0.07x | 0.45x | 0.02x |
| Net DebtTotal debt minus cash | -$4M | -$91M | $23M | $126M | -$144M |
| Cash & Equiv.Liquid assets | $7M | $101M | $41M | $239M | $158M |
| Total DebtShort + long-term debt | $3M | $10M | $64M | $364M | $14M |
| Interest CoverageEBIT ÷ Interest expense | — | 4.64x | -5.99x | 15.14x | 50.32x |
Total Returns (Dividends Reinvested)
Evenly matched — QNST and AVAV each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVAV five years ago would be worth $15,366 today (with dividends reinvested), compared to $1,999 for USNA. Over the past 12 months, NUS leads with a +26.3% total return vs USNA's -31.4%. The 3-year compound annual growth rate (CAGR) favors QNST at 21.9% vs NUS's -38.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.1% | -5.1% | -34.4% | -26.9% | +0.1% |
| 1-Year ReturnPast 12 months | -20.7% | -26.9% | +5.1% | +26.3% | -31.4% |
| 3-Year ReturnCumulative with dividends | -5.7% | +81.0% | +63.1% | -77.1% | -70.7% |
| 5-Year ReturnCumulative with dividends | -9.6% | -28.4% | +53.7% | -80.0% | -80.0% |
| 10-Year ReturnCumulative with dividends | -63.6% | +288.4% | +498.3% | -48.8% | -68.7% |
| CAGR (3Y)Annualised 3-year return | -1.9% | +21.9% | +17.7% | -38.9% | -33.6% |
Risk & Volatility
Evenly matched — NHTC and QNST each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHTC is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than AVAV's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. QNST currently trades 72.6% from its 52-week high vs AVAV's 40.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 1.23x | 1.57x | 1.49x | 1.34x |
| 52-Week HighHighest price in past year | $6.00 | $18.41 | $417.86 | $14.62 | $38.32 |
| 52-Week LowLowest price in past year | $2.40 | $10.29 | $155.69 | $5.65 | $16.60 |
| % of 52W HighCurrent price vs 52-week peak | +53.3% | +72.6% | +40.2% | +48.0% | +50.8% |
| RSI (14)Momentum oscillator 0–100 | 57.9 | 53.3 | 39.8 | 46.4 | 59.0 |
| Avg Volume (50D)Average daily shares traded | 25K | 673K | 1.7M | 458K | 118K |
Analyst Outlook
NHTC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: QNST as "Buy", AVAV as "Buy", NUS as "Hold", USNA as "Hold". Consensus price targets imply 104.3% upside for AVAV (target: $344) vs 12.3% for QNST (target: $15). For income investors, NHTC offers the higher dividend yield at 25.04% vs NUS's 3.35%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $15.00 | $343.60 | $11.00 | $35.00 |
| # AnalystsCovering analysts | — | 13 | 28 | 11 | 8 |
| Dividend YieldAnnual dividend ÷ price | +25.0% | — | — | +3.4% | — |
| Dividend StreakConsecutive years of raises | 0 | — | — | 0 | — |
| Dividend / ShareAnnual DPS | $0.80 | — | — | $0.24 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +5.8% | +7.7% |
NUS leads in 1 of 6 categories (Valuation Metrics). USNA leads in 1 (Profitability & Efficiency). 3 tied.
NHTC vs QNST vs AVAV vs NUS vs USNA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NHTC or QNST or AVAV or NUS or USNA a better buy right now?
For growth investors, QuinStreet, Inc.
(QNST) is the stronger pick with 78. 3% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate QuinStreet, Inc. (QNST) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NHTC or QNST or AVAV or NUS or USNA?
On trailing P/E, Nu Skin Enterprises, Inc.
(NUS) is the cheapest at 2. 2x versus QuinStreet, Inc. at 165. 6x. On forward P/E, Nu Skin Enterprises, Inc. is actually cheaper at 7. 0x.
03Which is the better long-term investment — NHTC or QNST or AVAV or NUS or USNA?
Over the past 5 years, AeroVironment, Inc.
(AVAV) delivered a total return of +53. 7%, compared to -80. 0% for USANA Health Sciences, Inc. (USNA). Over 10 years, the gap is even starker: AVAV returned +498. 3% versus USNA's -68. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NHTC or QNST or AVAV or NUS or USNA?
By beta (market sensitivity over 5 years), Natural Health Trends Corp.
(NHTC) is the lower-risk stock at 0. 58β versus AeroVironment, Inc. 's 1. 57β — meaning AVAV is approximately 171% more volatile than NHTC relative to the S&P 500. On balance sheet safety, USANA Health Sciences, Inc. (USNA) carries a lower debt/equity ratio of 2% versus 45% for Nu Skin Enterprises, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NHTC or QNST or AVAV or NUS or USNA?
By revenue growth (latest reported year), QuinStreet, Inc.
(QNST) is pulling ahead at 78. 3% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to -254. 0% for Natural Health Trends Corp.. Over a 3-year CAGR, QNST leads at 23. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NHTC or QNST or AVAV or NUS or USNA?
Nu Skin Enterprises, Inc.
(NUS) is the more profitable company, earning 10. 8% net margin versus -2. 2% for Natural Health Trends Corp. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUS leads at 6. 1% versus -4. 5% for NHTC. At the gross margin level — before operating expenses — USNA leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NHTC or QNST or AVAV or NUS or USNA more undervalued right now?
On forward earnings alone, Nu Skin Enterprises, Inc.
(NUS) trades at 7. 0x forward P/E versus 58. 4x for AeroVironment, Inc. — 51. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVAV: 104. 3% to $343. 60.
08Which pays a better dividend — NHTC or QNST or AVAV or NUS or USNA?
In this comparison, NHTC (25.
0% yield), NUS (3. 4% yield) pay a dividend. QNST, AVAV, USNA do not pay a meaningful dividend and should not be held primarily for income.
09Is NHTC or QNST or AVAV or NUS or USNA better for a retirement portfolio?
For long-horizon retirement investors, Natural Health Trends Corp.
(NHTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 58), 25. 0% yield). Both have compounded well over 10 years (NHTC: -63. 6%, USNA: -68. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NHTC and QNST and AVAV and NUS and USNA?
These companies operate in different sectors (NHTC (Consumer Cyclical) and QNST (Communication Services) and AVAV (Industrials) and NUS (Consumer Defensive) and USNA (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NHTC is a small-cap income-oriented stock; QNST is a small-cap high-growth stock; AVAV is a small-cap quality compounder stock; NUS is a small-cap deep-value stock; USNA is a small-cap quality compounder stock. NHTC, NUS pay a dividend while QNST, AVAV, USNA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.